1. Home > Latest Topics >

Question 14: Levofloxacin vs. clarithromycin study overview

20 June, 2018

question_14_6


LATEST TOPICS

Navigating antibiotic resistance in community-acquired pneumonia: Insights from Vietnam
29 October, 2024
Optimising antibiotic therapy: Insights on transitioning from intravenous to oral treatment for community-acquired pneumonia
27 September, 2024
Community-acquired pneumonia in Cambodia: Navigating the growing challenge of AMR
30 June, 2024
Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024

RELATED ARTICLES

Nontuberculous Mycobacteria (NTM) Diseases: Implementing Standardized Treatment
02 January, 2024
Management of community-acquired pneumonia in outpatient and inpatient settings: An overview
19 September, 2022
Levofloxacin in the Treatment of Hospital-Acquired Pneumonia: Insights into Antibiotic Resistance and Tolerance
18 October, 2023
Helicobacter pylori infections: A review of the current standard of care
16 February, 2022
Management of urinary tract infections: An overview
20 December, 2023